Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Unravelling Long COVID ; : 57-77, 2022.
Article in English | Scopus | ID: covidwho-2247115

ABSTRACT

Long COVID was called the first illness created through patients connecting with each other. Physicians have suggested that these symptoms are "medicine's blind spot". This chapter focuses on the common long COVID symptoms that defy current explanations. Fatigue is one of the most common and poorly understood symptoms that plagues humans. Chronic fatigue is strongly associated with mood disturbances, particularly depression, sleep disturbances, and cognitive disturbances. Cognitive disturbances are common in the general population, increase with aging, and are present in many chronic medical disorders. Unexplained dyspnea is not uncommon in younger individuals and is most often attributed to deconditioning or hyper-ventilation. Chronic pain is the leading cause of work loss in the world. Headaches are the most common chronic pain disorder. Sleep disturbances in the general population are strongly associated with mood disturbances and chronic pain. © 2023 John Wiley & Sons Ltd. All rights reserved.

2.
Unravelling Long COVID ; : 3-23, 2022.
Article in English | Scopus | ID: covidwho-2247111

ABSTRACT

Long COVID is a new term, introduced by patients, to account for multiple symptoms that last months and interfere with daily life, yet have no clear medical explanation. Disease is defined by organ damage, such as when a biopsy reveals cancer. A disease is characterized by its symptoms, such as pain or exhaustion, as well as physical signs, such as fever or swelling. Well-controlled studies have demonstrated that patients hospitalized with COVID-19 have much greater, persistent health problems than uninfected subjects. Women had more long-COVID symptoms than men, including greater fatigue, anxiety, or depression, and greater dyspnea, which was documented with abnormal pulmonary function testing. In controlled reports comparing hospitalized COVID-19 patients to noninfected community controls, about 10% of patients meet criteria for long COVID at three to six months after hospital discharge. Neuropsychiatric symptoms, including cognitive disturbances, particularly confusion, and mood disturbances were much more common in the non-hospitalized patients. © 2023 John Wiley & Sons Ltd. All rights reserved.

3.
J Neurol ; 269(7): 3400-3412, 2022 Jul.
Article in English | MEDLINE | ID: covidwho-1729300

ABSTRACT

BACKGROUND AND OBJECTIVES: To explore cognitive, EEG, and MRI features in COVID-19 survivors up to 10 months after hospital discharge. METHODS: Adult patients with a recent diagnosis of COVID-19 and reporting subsequent cognitive complaints underwent neuropsychological assessment and 19-channel-EEG within 2 months (baseline, N = 49) and 10 months (follow-up, N = 33) after hospital discharge. A brain MRI was obtained for 36 patients at baseline. Matched healthy controls were included. Using eLORETA, EEG regional current densities and linear lagged connectivity values were estimated. Total brain and white matter hyperintensities (WMH) volumes were measured. Clinical and instrumental data were evaluated between patients and controls at baseline, and within patient whole group and with/without dysgeusia/hyposmia subgroups over time. Correlations among findings at each timepoint were computed. RESULTS: At baseline, 53% and 28% of patients showed cognitive and psychopathological disturbances, respectively, with executive dysfunctions correlating with acute-phase respiratory distress. Compared to healthy controls, patients also showed higher regional current density and connectivity at delta band, correlating with executive performances, and greater WMH load, correlating with verbal memory deficits. A reduction of cognitive impairment and delta band EEG connectivity were observed over time, while psychopathological symptoms persisted. Patients with acute dysgeusia/hyposmia showed lower improvement at memory tests than those without. Lower EEG delta band at baseline predicted worse cognitive functioning at follow-up. DISCUSSION: COVID-19 patients showed interrelated cognitive, EEG, and MRI abnormalities 2 months after hospital discharge. Cognitive and EEG findings improved at 10 months. Dysgeusia and hyposmia during acute COVID-19 were related with increased vulnerability in memory functions over time.


Subject(s)
COVID-19 , Cognitive Dysfunction , Adult , Anosmia , COVID-19/complications , Cognition , Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/etiology , Cognitive Dysfunction/pathology , Dysgeusia , Electroencephalography , Humans , Magnetic Resonance Imaging , Neuropsychological Tests , Survivors
SELECTION OF CITATIONS
SEARCH DETAIL